Viewing Study NCT00224393


Ignite Creation Date: 2025-12-25 @ 12:57 AM
Ignite Modification Date: 2026-07-10 @ 10:48 AM
Study NCT ID: NCT00224393
Status: COMPLETED
Last Update Posted: 2023-05-30
First Post: 2005-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
Sponsor: The Cleveland Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Systemic Amyloidosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Amyloidosis View
None Enbrel View